MarketInOut Stock Screener Log In | Sign Up

U.S. Stem Cell Inc

OTC • Healthcare • Biotechnology • Quote as of 11/13/2026
U.S. Stem Cell Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.0641 mln
Float564 mln

Relative Strength

59 / 100
Slightly ahead

Pre-Tax Margin

-3,483%
Severely loss-making

ROE

20.78
Strong

ROA

-1,807
Deeply negative

Business Description

U.S. Stem Cell Inc. is an American company focused on developing therapies that use the body's own cells to treat heart conditions, with several treatments currently in or approaching clinical trials. The company also supports veterinary medicine with regenerative solutions and trains physicians in stem cell procedures. Founded in 1999 and based in Sunrise, Florida, it operates both domestically and abroad.

Key Fundamentals

EPS-0.00
ROE20.78
RPS0.00
ROIC29.95
ROA-1,807
Interest Cover-2.49
EBITDA, mln-2.02
EV / EBITDA-4.21
Revenue, mln0.08
EV / Revenue124

Quote Details

Last 0.000001
Change -0.000099 (-99%)
Open 0.000001
Volume 1,000
Turnover 0.001
Average Volume 234,521

Financial Ratios

Pre-Tax Profit Margin-3,483
Current Ratio0.00
Price / Sales2.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 56 / 100   
1 Month -99% 0 / 100   
2 Months 0% 67 / 100   
6 Months -99% 1 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog